A stratified precision medicine trial targeting α(2A)-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.
- DOI
- 10.1038/s44220-025-00510-7
- Published
- 2025
- Container
- Nature. Mental health
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44220-025-00510-7,
title = {A stratified precision medicine trial targeting α(2A)-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.},
author = {Hack LM and Jubeir J and Hilton R and Tozzi L and Boyar L and Zhang X and Lyons T and Jo B and O'Hara R and Schatzberg AF and Williams LM},
year = {2025},
journal = {Nature. Mental health},
doi = {10.1038/s44220-025-00510-7},
url = {https://doi.org/10.1038/s44220-025-00510-7}
}RIS
TY - JOUR TI - A stratified precision medicine trial targeting α(2A)-adrenergic receptor agonism as a treatment for the cognitive biotype of depression. AU - Hack LM AU - Jubeir J AU - Hilton R AU - Tozzi L AU - Boyar L AU - Zhang X AU - Lyons T AU - Jo B AU - O'Hara R AU - Schatzberg AF AU - Williams LM PY - 2025 JO - Nature. Mental health DO - 10.1038/s44220-025-00510-7 UR - https://doi.org/10.1038/s44220-025-00510-7 ER -
APA
LM, H., J, J., R, H., L, T., L, B., X, Z., T, L., B, J., R, O., AF, S., & LM, W. (2025). A stratified precision medicine trial targeting α(2A)-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.. Nature. Mental health. https://doi.org/10.1038/s44220-025-00510-7
Source records
- pubmed · retrieved 2026-09-26T18:02:22.037Z